Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 38, 2024 - Issue 13
407
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Two new cycloartane type triterpenes from Dysoxyllum binectariferum

, , , , , ORCID Icon & ORCID Icon show all
Pages 2288-2295 | Received 14 Nov 2022, Accepted 14 Jan 2023, Published online: 29 Jan 2023

References

  • Ahmad H, Ahmad S, Khan E, Shahzad A, Ali M, Tahir MN, Shaheen F, Ahmad M. 2017. Isolation, crystal structure determination and cholinesterase inhibitory potential of isotalatizidine hydrate from Delphinium denudatum. Pharm Biol. 55(1):680–686.
  • Ahmad S, Ahmad H, Khan HU, Shahzad A, Khan E, Shah SAA, Ali M, Wadud A, Ghufran M, Naz H, et al. 2016. Crystal structure, phytochemical study and enzyme inhibition activity of Ajaconine and Delectinine. J Mol Struct. 1123:441–448.
  • Ankalge R, Jagdale M, Ghaytidak S, Patil K, Manani L, Desai S. 2021. Pharmacognostic evaluation of leaves of Dysoxylum binectariferum. Phytomed Plus. 1(4):100149.
  • Darshani P, Sarma SS, Srivastava AK, Baishya R, Kumar D. 2022. Anti-viral triterpenes: a review. Phytochem Rev. 21(6):1761–1842.
  • Galal A, Raman V, Khan IA. 2015. Sida cordifolia, a traditional herb in modern perspective -a review. Curr Trad Med. 1(1):5–17.
  • Hisham A, Jayakumar G, Bai MDA, Fujimoto Y. 2004. Beddomeilactone: a new triterpene from Dysoxylum Beddomei. Nat Prod Res. 18(4):329–334.
  • Kumar D, Ghosh R, Pal BC. 2013. α-Glucosidase inhibitory terpenoids from Potentilla fulgens and their quantitative estimation by validated HPLC method. J Funct Foods. 5(3):1135–1141.
  • Kumar V, Gupta M, Gandhi SG, Bharate SS, Kumar A, Vishwakarma RA, Bharate SB. 2017. Anti-inflammatory chromone alkaloids and glycoside from Dysoxylum binectariferum. Tetrahedron Lett. 58(42):3974–3978.
  • Kumar V, Bharate SS, Bhurta D, Gupta M, Gandhi SG, Singh D, Jaglan S, Kumar A, Vishwakarma RA, Bharate SB. 2020. Evaluation of rohitukine-enriched fraction of Dysoxylum binectariferum Hook.f. (leaves) as anti-arthritic phytopharmaceutical candidate: chemical standardization, in-vivo validation, formulation development and oral pharmacokinetics. J Ethnopharmacol. 254:112758.
  • Meilanie SR, Mayanti T, Nurlelasari N, Huspa DHP, Maharani R, Zainuddin A, Darwati D, Julaeha E, Supratman U, Anshori JA. 2022. Triterpenoids from Stem Bark of Dysoxylum excelsum and Their Cytotoxic Activity against MCF-7 Breast Cancer Cells. Indones J Chem. 22(4):1107–1115.
  • Naini AA, Mayanti T, Supratman U. 2022. Triterpenoids from Dysoxylum genus and their biological activities. Arch Pharm Res. 45(2):63–89.
  • Parcha V, Gahlot M, Kaur J, Tomar Y. 2004. A review on phytochemical and pharmacological studies of Dysoxylum species. J Nat Remedies. 4(1):1–11.
  • Pujirahayu N, Bhattacharjya DK, Suzuki T, Katayama T. 2019. α-Glucosidase inhibitory activity of cycloartane-type triterpenes isolated from indonesian stingless bee propolis and their structure-activity relationship. Pharmaceuticals. 12(3):102.
  • Singh M, Krishnan AAV, Mandal R, Samanta J, Ravichandiran V, Natarajan R, Bharitkar YP, Hazra A. 2020. Azomethine ylide cycloaddition: a versatile tool for preparing novel pyrrolizidino-spiro-oxindolo hybrids of the doubly conjugated alkamide piperine. Mol Divers. 24(3):627–639.
  • Tavarez-Santamaría Z, Jacobo-Herrera NJ, Rocha-Zavaleta L, Zentella-Dehesa A, Couder-García B del C, Martínez-Vázquez M. 2020. A higher frequency administration of the nontoxic cycloartane-type triterpene argentatin A improved its anti-tumor activity. Molecules. 25(8):1780.
  • Yan HJ, Si HL, Zhao HW, Chen L, Yu JQ, Zhao HQ, Wang X. 2021. Four new cycloartane triterpenoids from the leaves of Dysoxylum binectariferum. Phytochem Lett. 41:101–105.
  • Zareen S, Choudhary MI, Akhtar MN, Khan, SN, Atta-Ur-Rahman. 2008. α-glucosidase inhibitory activity of triterpenoids from Cichorium intybus. J Nat Prod. 71(5):910–913.,
  • Zhang LB, Chang JJ, Guo LM, Lv JL. 2020. Triterpenoids with α-glucosidase inhibitory activity from Artemisia argyi. J Asian Nat Prod Res. 22(3):241–248.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.